Zoersel, Belgium

Laurent Lefort

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurent Lefort. Retrieved from https://idiyas.com/inventor/laurent-lefort-d0csms94

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Laurent Lefort

Introduction

Laurent Lefort is a notable inventor based in Zoersel, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors that play a crucial role in treating various diseases.

Latest Patents

Laurent Lefort holds a patent for "Processes and intermediates for preparing a Btk inhibitor." This patent discloses a process for the preparation of certain intermediates, specifically a compound of formula (I) or a pharmaceutically acceptable salt thereof, in an enantioenriched form. These intermediates and processes are essential in the preparation of a BTK inhibitor, such as ibrutinib. He has 1 patent to his name.

Career Highlights

Lefort is currently employed at Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work focuses on innovative processes that enhance the efficacy of drug development.

Collaborations

Laurent has collaborated with esteemed colleagues, including Philip James Pye and Andras Horvath, to advance research and development in his field.

Conclusion

Laurent Lefort's contributions to the pharmaceutical industry, particularly through his patent on Btk inhibitors, highlight his role as an influential inventor. His work continues to impact the development of critical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…